Recursion (RXRX) stock dips after $200M equity offering despite Sanofi (SNY) choosing its first AI drug candidate under a ...

Leading Healthcare Investors, including Janus Henderson Investors, Invus, Longaeva Partners, ARK Invest, Driehaus Capital Management and other prominent healthcare specialists and mutual funds invest ...

You can now hyperpersonalize your YouTube algorithm using plain language. On Wednesday, Google announced several new, mostly AI-driven features for YouTube. One standout is the Custom Feeds button, ...

Recommendation algorithms promise social media users a personalized experience, but some experts worry they promote doomscrolling, brain rot, and myriad mental health problems. Australia recently ...

“[The IRS] is using AI to identify targets for who’s going to be audited,” Rob Kovacev, a tax lawyer at Miller & Chevalier, told Inc. “They’re doing that at all levels, for everything—from small ...

Factorial Energy has signed a joint development agreement with Japan’s Mitsui Kinzoku for solid electrolytes, the latest in a run of partnerships its chief executive says are necessary because no ...

Solid-state battery specialist Factorial Energy is teaming up with Mitsui Kinzoku, one of the few companies producing sulfide-based solid electrolytes, to scale up the promising new technology.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Anthropic co-founder Dario Amodei urges a deliberate slowdown in AI development, emphasizing ...

Social media platforms could be forced to give users in Australia an option to turn off “powerful” algorithms under draft laws to be unveiled by the government this week, Communications Minister Anika ...

Factorial Funds, a venture firm launched five years ago by former Cruise engineer Sol Bier, has crossed $1 billion in realized profits, according to a letter the firm is sharing with its investors.

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...